S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
66,000% upside on tiny biotech? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
66,000% upside on tiny biotech? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
66,000% upside on tiny biotech? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
66,000% upside on tiny biotech? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
NASDAQ:ARDX

Ardelyx (ARDX) Price Target & Analyst Ratings

$3.93
+0.17 (+4.52%)
(As of 06/8/2023 ET)
Compare
Today's Range
$3.74
$4.00
50-Day Range
$3.23
$4.95
52-Week Range
$0.49
$5.13
Volume
5.14 million shs
Average Volume
6.62 million shs
Market Capitalization
$842.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25

Ardelyx Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$6.25
59.03% Upside
High Prediction$8.00
Average Prediction$6.25
Low Prediction$3.00
TypeCurrent
6/9/22 to 6/9/23
1 Month Ago
5/10/22 to 5/10/23
3 Months Ago
3/11/22 to 3/11/23
1 Year Ago
6/9/21 to 6/9/22
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$6.25$6.25$6.00$5.24
Predicted Upside59.03% Upside123.21% Upside190.95% Upside123.53% Upside
Get Ardelyx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.


ARDX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ARDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ardelyx Stock vs. The Competition

TypeArdelyxMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.48
Consensus RatingBuyBuyHold
Predicted Upside59.03% Upside1,171.49% Upside228.81% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/17/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Chico
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$6.00 ➝ $7.00+44.03%
12/30/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$6.00 ➝ $7.00+176.68%
12/29/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$1.60 ➝ $3.00+26.05%
11/17/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$3.00 ➝ $8.00+555.73%
(Data available from 6/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ARDX Price Target - Frequently Asked Questions

What is Ardelyx's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Ardelyx stock is Buy based on the current 3 buy ratings for ARDX. The average twelve-month price prediction for Ardelyx is $6.25 with a high price target of $8.00 and a low price target of $3.00. Learn more on ARDX's analyst rating history.

Do Wall Street analysts like Ardelyx more than its competitors?

Analysts like Ardelyx more than other Medical companies. The consensus rating score for Ardelyx is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how ARDX compares to other companies.

Does Ardelyx's stock price have much upside?

According to analysts, Ardelyx's stock has a predicted upside of 123.21% based on their 12-month price targets.

What analysts cover Ardelyx?

Ardelyx has been rated by Wedbush in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:ARDX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -